ITOT vs XBI
iShares Core S&P Total US Stock Market ETF vs SPDR S&P Biotech ETF
- • ITOT has the lower expense ratio at 0.03% vs 0.35% for XBI.
- • ITOT pays a higher dividend yield (1.00%).
Side-by-side metrics
| Metric | ITOT | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.00% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $94.14B | $10.73B |
YTD return | 10.55% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 1.10 |
P/E ratio | 26.44 | — |
Last price | $165.08 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
ITOT top holdings
| NVDA | NVIDIA Corp | 6.63% |
| AAPL | Apple Inc | 5.81% |
| MSFT | Microsoft Corp | 3.79% |
| AMZN | Amazon.com Inc | 3.19% |
| GOOGL | Alphabet Inc Class A | 2.86% |
| AVGO | Broadcom Inc | 2.45% |
| GOOG | Alphabet Inc Class C | 2.29% |
| MU | Micron Technology Inc | 1.78% |
| META | Meta Platforms Inc Class A | 1.69% |
| TSLA | Tesla Inc | 1.62% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ITOT
ITOT (iShares Core S&P Total US Stock Market ETF) is Total US equity market exposure. Managed by iShares, the fund carries $94.1B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.00%. Its largest holding is NVIDIA Corp (NVDA), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 2.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.